I-125 Versus Pd-103 for Low Risk Prostate Cancer

Status unconfirmed · Phase 3

Conditions studied: Prostate Cancer

In brief

Objective: To test the hypothesis that the shorter half-life of Pd-103 versus I-125, will increase the rate of tumor eradication. Research design A total of 600 patients with AJC clinical stage T1c-T2a prostatic carcinoma (Gleason grade 2 to 6, PSA 4 to 10 ng/ml) will be randomized to implantation with I-125 (160 Gy) versus Pd-103 (115 Gy).

Key facts

Study ID

NCT00494039

Run by

VA Puget Sound Health Care System

People needed

602

Starts

1998-01-01

Expected to finish

2010-01-01

Last updated by the study team

2007-06-29

Who can join

Age: 40 and older, up to 80. Sex: male. Healthy volunteers: not accepted.

You may qualify if…

• Males age 40-80
• PSA 4-10
• Gleason score 5-6

You may not qualify if…

• Lymph node positive

Where it is running

• Puget Sound VA — Seattle, Washington, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.